We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Original Investigation |

Association of Depression With Accelerated Cognitive Decline Among Patients With Type 2 Diabetes in the ACCORD-MIND Trial

Mark D. Sullivan, MD, PhD1; Wayne J. Katon, MD1; Laura C. Lovato, MA2; Michael E. Miller, PhD2; Anne M. Murray, MD3; Karen R. Horowitz, MD4; R. Nick Bryan, MD5; Hertzel C. Gerstein, MD6; Santica Marcovina, MD1; Basil E. Akpunonu, MD7; Janice Johnson, BA1; Jean Francois Yale, MD8; Jeff Williamson, MD2; Lenore J. Launer, PhD9
[+] Author Affiliations
1Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington
2Department of Public Health Sciences, Wake Forest University, Winston-Salem, North Carolina
3Department of Internal Medicine, University of Minnesota, Minneapolis, Minnesota
4Department of Internal Medicine, Case-Western University, Cleveland, Ohio
5Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania
6Department of Internal Medicine, McMaster University, Hamilton, Ontario, Canada
7Department of Medicine, University of Toledo, Toledo, Ohio
8Department of Internal Medicine, McGill University, Montreal, Quebec, Canada
9National Institute on Aging, Bethesda, Maryland
JAMA Psychiatry. 2013;70(10):1041-1047. doi:10.1001/jamapsychiatry.2013.1965.
Text Size: A A A
Published online

Importance  Depression has been identified as a risk factor for dementia among patients with type 2 diabetes mellitus but the cognitive domains and patient groups most affected have not been identified.

Objective  To determine whether comorbid depression in patients with type 2 diabetes accelerates cognitive decline.

Design  A 40-month cohort study of participants in the Action to Control Cardiovascular Risk in Diabetes–Memory in Diabetes (ACCORD-MIND) trial.

Setting  Fifty-two clinics organized into 6 clinical networks across the United States and Canada.

Participants  Two thousand nine hundred seventy-seven participants with type 2 diabetes at high risk for cardiovascular events.

Intervention  The Digit Symbol Substitution Test, Rey Auditory Verbal Learning Test, and the modified Stroop test were used to assess cognition. The 9-item Patient Health Questionnaire was used to assess depression.

Main Outcomes and Measures  Mixed-effects statistical models were used to analyze cognitive test outcomes incorporating depression as a time-dependent covariate.

Results  Participants with scores indicative of depression (9-item Patient Health Questionnaire, ≥10) showed greater cognitive decline during 40-month follow-up on all tests, with the following differences in estimated least squares means: Digit Symbol Substitution Test, 0.72 (95% CI, 0.25 to 1.19; P = .003), Rey Auditory Verbal Learning Test, 0.18 (95% CI, 0.07 to 0.29; P = .001), and Stroop interference, −1.06 (95% CI, −1.93 to −0.18; P = .02). This effect of depression on risk of cognitive decline did not differ according to previous cardiovascular disease; baseline cognition or age; or intensive vs standard glucose-lowering treatment, blood pressure treatment, lipid treatment, or insulin treatment. Addition of demographic and clinical covariates to models did not significantly change the cognitive decline associated with depression.

Conclusions and Relevance  Depression in patients with type 2 diabetes was associated with greater cognitive decline in all domains, across all treatment arms, and in all participant subgroups assessed. Future randomized trials will be necessary to determine if depression treatment can lower the risk of cognitive decline in patients with diabetes.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 7

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections